SCOTTISH-BASED PhaSER Biomedical (PhaSER) has agreed to a long-term partnership with the Sanders Tri-Institutional Therapeutic Discovery Institute, Inc. (TDI) to enhance the institute’s groundbreaking pre-clinical drug discovery research. Headquartered in